SCHEMBL19086247

SCHEMBL19086247

O=CN1CCc2sc(C(=O)N3CCOCC3)cc2C1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.48
SMO Q99835 2/20 0.48
HPGD P15428 4/20 0.48
ALDH1A1 P00352 8/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
USP2 O75604 1/20 0.46
POLB P06746 1/20 0.46
NR4A1 P22736 1/20 0.46
RECQL P46063 1/20 0.46
BLM P54132 1/20 0.46
ESR2 Q92731 1/20 0.46
CTDSP1 Q9GZU7 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
KDM4E B2RXH2 2/20 0.42
MAPT P10636 2/20 0.42
CYP1A2 P05177 2/20 0.42
CYP2C19 P33261 2/20 0.42
CYP3A4 P08684 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6423341 0.75 USP2 (0.49) L3MBTL1SMOHPGDALDH1A1USP2
SCHEMBL19086231 0.75 ALDH1A1 (0.56) HPGDALDH1A1MEN1KMT2APOLB
SCHEMBL6423315 0.74 TPSAB1 (0.61) L3MBTL1HPGDALDH1A1MEN1KMT2A
SCHEMBL19086350 0.72 MAPT (0.48) SMOHPGDALDH1A1MEN1KMT2A
SCHEMBL19086022 0.71 RAB9A (0.56) HPGDALDH1A1MEN1KMT2AUSP2
SCHEMBL21428365 0.69 PDE4D (0.44) SMN1; SMN2NPC1RAB9A
SCHEMBL19086320 0.69 KDM4E (0.56) L3MBTL1HPGDALDH1A1MEN1KMT2A
SCHEMBL19086996 0.67 NPC1 (0.45) ALDH1A1USP2SMN1; SMN2NPC1RAB9A
SCHEMBL19087009 0.67 ALDH1A1 (0.49) L3MBTL1HPGDALDH1A1MEN1KMT2A
SCHEMBL1474629 0.66 HPGD (0.57) L3MBTL1HPGDALDH1A1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017114275-A1 COMPOUND FOR INHIBITING ROCK, PREPARATION METHOD AND USE OF SAME 成都先导药物开发有限公司 2017-07-06 WO disclosed